3–6 Months | 15–18 Months | |||||
---|---|---|---|---|---|---|
HydroCoil (No.) (%) | Bare Platinum (No.) (%) | P | HydroCoil (No.) (%) | Bare Platinum (No.) (%) | P | |
No. of patients with angiographic follow-up | 56 | 50 | – | 59 | 59 | – |
No. of patients clinical follow-up | 63 | 64 | – | 65 | 65 | – |
Any recurrence | 14 (25.0) | 24 (48.0) | .02a | 22 (37.3) | 38 (64.4) | .006a |
Major recurrence | 4 (7.1) | 13 (26.0) | .02a | 12 (20.3) | 28 (47.5) | .003a |
Retreatment | 0 (0.0) | 0 (0.0) | 1.0 | 0 (0.0) | 2 (3.4) | .50 |
mRS ≤ 2 | 54 (85.7) | 56 (87.5) | .80 | 56 (86.2) | 59 (90.8) | .58 |
↵a Significant.